Phototherapy: Treatment of disease by exposure to light, especially by variously concentrated light rays or specific wavelengths.Ultraviolet Therapy: The use of ultraviolet electromagnetic radiation in the treatment of disease, usually of the skin. This is the part of the sun's spectrum that causes sunburn and tanning. Ultraviolet A, used in PUVA, is closer to visible light and less damaging than Ultraviolet B, which is ionizing.Jaundice, Neonatal: Yellow discoloration of the SKIN; MUCOUS MEMBRANE; and SCLERA in the NEWBORN. It is a sign of NEONATAL HYPERBILIRUBINEMIA. Most cases are transient self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) occurring in the first week of life, but some can be a sign of pathological disorders, particularly LIVER DISEASES.PUVA Therapy: Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA).Hyperbilirubinemia, Neonatal: Accumulation of BILIRUBIN, a breakdown product of HEME PROTEINS, in the BLOOD during the first weeks of life. This may lead to NEONATAL JAUNDICE. The excess bilirubin may exist in the unconjugated (indirect) or the conjugated (direct) form. The condition may be self-limiting (PHYSIOLOGICAL NEONATAL JAUNDICE) or pathological with toxic levels of bilirubin.Bilirubin: A bile pigment that is a degradation product of HEME.Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis.Hyperbilirubinemia: A condition characterized by an abnormal increase of BILIRUBIN in the blood, which may result in JAUNDICE. Bilirubin, a breakdown product of HEME, is normally excreted in the BILE or further catabolized before excretion in the urine.Exchange Transfusion, Whole Blood: Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.Infant, Newborn: An infant during the first month after birth.Scleroderma, Localized: A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules.Eye Protective Devices: Personal devices for protection of the eyes from impact, flying objects, glare, liquids, or injurious radiation.Durable Medical Equipment: Devices which are very resistant to wear and may be used over a long period of time. They include items such as wheelchairs, hospital beds, artificial limbs, etc.Kernicterus: A term used pathologically to describe BILIRUBIN staining of the BASAL GANGLIA; BRAIN STEM; and CEREBELLUM and clinically to describe a syndrome associated with HYPERBILIRUBINEMIA. Clinical features include athetosis, MUSCLE SPASTICITY or hypotonia, impaired vertical gaze, and DEAFNESS. Nonconjugated bilirubin enters the brain and acts as a neurotoxin, often in association with conditions that impair the BLOOD-BRAIN BARRIER (e.g., SEPSIS). This condition occurs primarily in neonates (INFANT, NEWBORN), but may rarely occur in adults. (Menkes, Textbook of Child Neurology, 5th ed, p613)Vitiligo: A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.Laser Therapy, Low-Level: Treatment using irradiation with LASER light of low power intensity so that the effects are not due to heat, as they are in LASER THERAPY.Hematoporphyrin Derivative: A complex mixture of monomeric and aggregated porphyrins used in the photodynamic therapy of tumors (HEMATOPORPHYRIN PHOTORADIATION). A purified component of this mixture is known as DIHEMATOPORPHYRIN ETHER.Hematoporphyrins: Iron-free derivatives of heme with 4 methyl groups, 2 hydroxyethyl groups and 2 propionic acid groups attached to the pyrrole rings. Some of these PHOTOSENSITIZING AGENTS are used in the PHOTOTHERAPY of malignant NEOPLASMS.Rats, Gunn: Mutant strain of Rattus norvegicus which is used as a disease model of kernicterus.Acitretin: An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.Parakeratosis: Persistence of the nuclei of the keratinocytes into the stratum corneum of the skin. This is a normal state only in the epithelium of true mucous membranes in the mouth and vagina. (Dorland, 27th ed)Photosensitizing Agents: Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.Jaundice: A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.Home Care Services: Community health and NURSING SERVICES providing coordinated multiple services to the patient at the patient's homes. These home-care services are provided by a visiting nurse, home health agencies, HOSPITALS, or organized community groups using professional staff for care delivery. It differs from HOME NURSING which is provided by non-professionals.Nurseries, Hospital: Hospital facilities which provide care for newborn infants.Bile Pigments: Linear TETRAPYRROLES that give a characteristic color to BILE including: BILIRUBIN; BILIVERDIN; and bilicyanin.Hypopigmentation: A condition caused by a deficiency or a loss of melanin pigmentation in the epidermis, also known as hypomelanosis. Hypopigmentation can be localized or generalized, and may result from genetic defects, trauma, inflammation, or infections.Parapsoriasis: The term applied to a group of relatively uncommon inflammatory, maculopapular, scaly eruptions of unknown etiology and resistant to conventional treatment. Eruptions are both psoriatic and lichenoid in appearance, but the diseases are distinct from psoriasis, lichen planus, or other recognized dermatoses. Proposed nomenclature divides parapsoriasis into two distinct subgroups, PITYRIASIS LICHENOIDES and parapsoriasis en plaques (small- and large-plaque parapsoriasis).Hyperbilirubinemia, Hereditary: Inborn errors of bilirubin metabolism resulting in excessive amounts of bilirubin in the circulating blood, either because of increased bilirubin production or because of delayed clearance of bilirubin from the blood.Anthralin: An anthracene derivative that disrupts MITOCHONDRIA function and structure and is used for the treatment of DERMATOSES, especially PSORIASIS. It may cause FOLLICULITIS.Photochemotherapy: Therapy using oral or topical photosensitizing agents with subsequent exposure to light.Lichenoid Eruptions: Conditions in which there is histological damage to the lower epidermis along with a grouped chronic inflammatory infiltrate in the papillary dermis disturbing the interface between the epidermis and dermis. LICHEN PLANUS is the prototype of all lichenoid eruptions. (From Rook et al., Textbook of Dermatology, 4th ed, p398)Infant, Premature, DiseasesDermatology: A medical specialty concerned with the skin, its structure, functions, diseases, and treatment.Skin DiseasesTreatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Color Therapy: A form of phototherapy using color to influence health and to treat various physical or mental disorders. The color rays may be in the visible or invisible spectrum and can be administered through colored lights or applied mentally through suggestion.Erythema: Redness of the skin produced by congestion of the capillaries. This condition may result from a variety of causes.Erythroblastosis, Fetal: A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.Infant, Extremely Low Birth Weight: An infant whose weight at birth is less than 1000 grams (2.2 lbs), regardless of GESTATIONAL AGE.Protective Devices: Devices designed to provide personal protection against injury to individuals exposed to hazards in industry, sports, aviation, or daily activities.Methoxsalen: A naturally occurring furocoumarin compound found in several species of plants, including Psoralea corylifolia. It is a photoactive substance that forms DNA ADDUCTS in the presence of ultraviolet A irradiation.Forehead: The part of the face above the eyes.Dermatologic Agents: Drugs used to treat or prevent skin disorders or for the routine care of skin.Copyright: It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)Computer Security: Protective measures against unauthorized access to or interference with computer operating systems, telecommunications, or data structures, especially the modification, deletion, destruction, or release of data in computers. It includes methods of forestalling interference by computer viruses or so-called computer hackers aiming to compromise stored data.Confidentiality: The privacy of information and its protection against unauthorized disclosure.Privacy: The state of being free from intrusion or disturbance in one's private life or affairs. (Random House Unabridged Dictionary, 2d ed, 1993)Incubators: Insulated enclosures in which temperature, humidity, and other environmental conditions can be regulated at levels optimal for growth, hatching, reproduction, or metabolic reactions.Photography: Method of making images on a sensitized surface by exposure to light or other radiant energy.Photography, Dental: Photographic techniques used in ORTHODONTICS; DENTAL ESTHETICS; and patient education.Pathology, Surgical: A field of anatomical pathology in which living tissue is surgically removed for the purpose of diagnosis and treatment.Image Processing, Computer-Assisted: A technique of inputting two-dimensional images into a computer and then enhancing or analyzing the imagery into a form that is more useful to the human observer.Online Systems: Systems where the input data enter the computer directly from the point of origin (usually a terminal or workstation) and/or in which output data are transmitted directly to that terminal point of origin. (Sippl, Computer Dictionary, 4th ed)

Bright light treatment used for adaptation to night work and re-adaptation back to day life. A field study at an oil platform in the North Sea. (1/446)

Night workers complain of sleepiness, reduced performance and disturbed sleep due to lack of adjustment of the circadian rhythm. In simulated night-work experiments scheduled exposure to bright light has been shown to reduce these complaints. Here we studied the effects of bright light treatment on the adaptation to 14 days of consecutive night work at an oil platform in the North Sea, and the subsequent readaptation to day life at home, using the Karolinska sleep/wake diary. Bright light treatment of 30 min per exposure was applied during the first 4 nights of the night-shift period and the first 4 days at home following the shift period. The bright light exposure was scheduled individually to phase delay the circadian rhythm. Bright light treatment modestly facilitated the subjective adaptation to night work, but the positive effect of bright light was especially pronounced during the re-adaptation back to day life following the return home. Sleepiness was reduced and the quality of day was rated better after exposure to bright light. The modest effect of bright light at the platform was, possibly, related to the finding that the workers seemed to adapt to night work within a few days even without bright light. These results suggest that short-term bright light treatment may help the adaptation to an extended night-work period, and especially the subsequent re-adaptation to day life.  (+info)

Light treatment enhances photoreceptor survival in dystrophic retinas of Royal College of Surgeons rats. (2/446)

PURPOSE: To determine whether treatment with bright light elicits a protective response that enhances photoreceptor survival in Royal College of Surgeons (RCS) rats with inherited retinal degeneration. METHODS: RCS rats were illuminated for 10 to 12 hours with 130 foot-candles (fc) of white or green light. Untreated littermates that were kept under low cyclic light levels were used as control subjects. Photoreceptor survival was determined by quantitative analysis of photoreceptor nuclei and ultrastructural assessment of cellular organization. Basic fibroblast growth factor (bFGF) and ciliary neurotrophic factor (CNTF) gene expression were determined at the mRNA and protein levels. RESULTS: Treatments of RCS rats with a single dose of bright light on postnatal day 23 (P23) greatly enhanced photoreceptor survival. Ultrasturctural analysis revealed intact inner segments in light-treated retinas, whereas in untreated retinas only remnants of inner segments were observed. By P42, numerous viable nuclei were counted in the posterior retina of light-treated rats, whereas most of the remaining nuclei in untreated RCS rat retinas were highly pyknotic. At 2.5 days after treatment with a single dose of bright light, bFGF gene expression was significantly higher than in untreated RCS rat retinas. By P42, bFGF protein levels were still significantly higher in the treated retinas. CONCLUSIONS: Exogenous bFGF has been shown to promote photoreceptor survival in the RCS rat retina. Thus, the increased bFGF expression that was measured in the light-treated RCS rat retinas may be a protective response to light stress, which supports the observed rescue of photoreceptors in light-treated RCS rat retinas.  (+info)

Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. (3/446)

BACKGROUND: Patients with ovarian cancer that is clinically resistant to cisplatin-based chemotherapy have little hope of a cure of their disease. Photoimmunotherapy, which involves the antibody-targeted delivery of a nontoxic photosensitizer that is activated to a cytotoxic state with visible light, may offer a new treatment option. Photoimmunotherapy may be applied intraperitoneally to target disseminated tumor. We tested the hypothesis that this treatment in combination with cisplatin potentiates cytotoxicity in ovarian cancer cell lines and primary cultures of human tumors. METHODS: Five human cancer cell lines (ovarian and breast) and 19 primary cultures were studied. The primary cultures were from solid and ascites tumor samples obtained from 14 patients with ovarian cancer who were undergoing primary surgery. The photosensitizer chlorin e(6) was conjugated to the F(ab')(2) fragment of the murine monoclonal antibody OC-125, which is directed against the antigen CA 125. Cytotoxicity was measured by the microculture tetrazolium assay. Treatments consisted of cisplatin alone, photoimmunotherapy alone, and photoimmunotherapy followed by cisplatin. The fractional product method was used to assess synergy in treatment effects. Ex vivo cultured human cells exhibiting 80% or greater survival at cisplatin concentrations of 10 microM for 24 hours were defined as cisplatin resistant for this study. RESULTS: When all cell types (cisplatin sensitive and cisplatin resistant) were considered together, combination treatment yielded cytotoxicity that was, on average, 6.9 times (95% confidence interval = 1.86-11.94) greater than that of cisplatin alone (two-sided P =.023). Cisplatin-resistant cells showed a synergistic effect of the two treatments (two-sided P =.044), while cisplatin-sensitive cells showed an additive effect. CONCLUSION: These ex vivo data suggest that platinum resistance in human ovarian cancer cells may be reversible by pretreatment with OC-125-targeted photoimmunotherapy. Further studies are required to confirm the efficacy of this approach in vivo.  (+info)

Atopic dermatitis: a review of diagnosis and treatment. (4/446)

Atopic dermatitis is a common, potentially debilitating condition that can compromise quality of life. Its most frequent symptom is pruritus. Attempts to relieve the itch by scratching simply worsen the rash, creating a vicious circle. Treatment should be directed at limiting itching, repairing the skin and decreasing inflammation when necessary. Lubricants, antihistamines and topical corticosteroids are the mainstays of therapy. When required, oral corticosteroids can be used. If pruritus does not respond to treatment, other diagnoses, such as bacterial overgrowth or viral infections, should be considered. Treatment options are available for refractory atopic dermatitis, but these measures should be reserved for use in unique situations and typically require consultation with a dermatologist or an allergist.  (+info)

Intermittent bright light and exercise to entrain human circadian rhythms to night work. (5/446)

Bright light can phase shift human circadian rhythms, and recent studies have suggested that exercise can also produce phase shifts in humans. However, few studies have examined the phase-shifting effects of intermittent bright light, exercise, or the combination. This simulated night work field study included eight consecutive night shifts followed by daytime sleep/dark periods (delayed 9 h from baseline). There were 33 subjects in a 2 x 2 design that compared 1) intermittent bright light (6 pulses, 40-min long each, at 5,000 lx) versus dim light and 2) intermittent exercise (6 bouts, 15-min long each, at 50-60% of maximum heart rate) versus no exercise. Bright light and exercise occurred during the first 6 h of the first three night shifts. The circadian phase marker was the demasked rectal temperature minimum. Intermittent bright-light groups had significantly larger phase delays than dim-light groups, and 94% of subjects who received bright light had phase shifts large enough for the temperature minimum to reach daytime sleep. Exercise did not affect phase shifts; neither facilitating nor inhibiting phase shifts produced by bright light.  (+info)

Comparison of the treatment of herpes genitalis in men with proflavine photoinactivation, idoxuridine ointment, and normal saline. (6/446)

36 male patients with genital infection by HSV confirmed by culture were each allocated to one of three treatment groups: (1) Proflavine photoinactivation, (2) 0.5 per cent. idoxuridine ointment (IDU), (3) Normal saline. They were assessed objectively at each attendance by measurement of the lesions with an operating microscope fitted with a measuring grid in one eyepiece. Material for culture for HSV was taken at each visit; the presence of symptoms (pain, discomfort, and irritation) was noted. The areas of lesions in the proflavine photoinactivation group remained larger significantly longer than in the other groups, the healing time was slower, and HSV could be isolated for longer. It is concluded that proflavine photoinactivation is of no greater value than 0.5 per cent. IDU or normal saline in the treatment of genital infection by HSV in the male.  (+info)

The urinary concentrating defect in the Gunn strain of rat. Role of bilirubin. (7/446)

The role of high serum and tissue levels of unconjegated bilirubin in the pathogenesis of the impaired urinary concentrating ability was investigated in homozygous (jj) Gunn rats with the congenital absence of hepatic glucuronyl transferase. Continuous phototherapy with blue fluorescent lights at a wave length of 460 nm or oral cholestyramine feeding or both reduced serum levels of unconjugated hilirubin to levels consistently below 3.0 mg/100 ml for several weeks in both weanling and adult jj Gunn rats. The renal concentrating defect was already present in weanling jj Gunn rats by 21 days of age. In treated weanling jj animals, maximum concentrating ability and the concentration of urea and nonurea solutes in the papilla and medulla, determined after 24 h of fluid deprivation, were normal when compared to unaffected heterozygous (Jj) littermates. Solute-free water reabsorption which is reduced in jaundiced jj Gunn rats was restored to normal in treated weanling jj rats. The tissue concentration of unconjugated bilirubin was reduced throughout the papilla and inner and outer medulla in the treated jj rats in comparison with untreated jj littermates. The defect in urinary concentrating ability was only partially reversible and sometimes irreversible in adult jj rats, probably because of permanent renal parenchymal damage occurring secondary to massive crystalline deposits in the papilla and medulla. It is concluded that unconjugated bilirubin is directly involved in the pathogenesis of the concentrating defect in jaundiced jj Gunn rats.  (+info)

Light therapy for seasonal affective disorder in primary care: randomised controlled trial. (8/446)

BACKGROUND: Studies of light therapy have not been conducted previously in primary care. AIMS: To evaluate light therapy in primary care. METHOD: Fifty-seven participants with seasonal affective disorder were randomly allocated to 4 weeks of bright white or dim red light. Baseline expectations for treatment were assessed. Outcome was assessed with the Structured Interview Guide for the Hamilton Depression Scale, Seasonal Affective Disorder Version. RESULTS: Both groups showed decreases in symptom scores of more than 40%. There were no differences in proportions of responders in either group, regardless of the remission criteria applied, with around 60% (74% white light, 57% red light) meeting broad criteria for response and 31% (30% white light, 33% red light) meeting strict criteria. There were no differences in treatment expectations. CONCLUSIONS: Primary care patients with seasonal affective disorder improve after light therapy, but bright white light is not associated with greater improvements.  (+info)

  • This application will help you assess a neonates need for phototherapy using the National Institute for Health and Clinical Excellence (NICE) guidelines. (
  • One hundred and eighteen neonates were randomly assigned to phototherapy and 20% albumin (n = 59) and phototherapy and saline (n = 69). (
  • In the standard form of phototherapy, your baby lies in a bassinet or enclosed plastic crib (incubator) and is exposed to a type of fluorescent light that is absorbed by your baby's skin . (
  • A baby with jaundice may need to stay under a phototherapy light for several days. (
  • The WeeSpecs Supreme Phototherapy Mask has an anatomically contoured goggle design and dark fabric that provide superior light-blocking protection without placing pressure on the eyes. (
  • Texas Dermatology and Laser Specialists provides ultraviolet light and phototherapy treatments for a variety of skin conditions. (
  • Also called ultraviolet light therapy, with phototherapy the absorption of light waves into the skin promotes healing in a number of ways. (
  • LED phototherapy uses a narrow band, non-thermal, LED light energy, to trigger your body's natural cell processes that can stimulate cell production, accelerate the rejuvenation process, kill Acne causing bacteria and can help to heal and repair skin. (
  • Light therapy - also called phototherapy - uses a full-spectrum lamp or portable visor, usually 10,000 lux in intensity, for 30-90 minutes at the patient's usual time of spontaneous awakening, or shortly before. (
  • (
  • Red light therapy is a form of phototherapy, which involved being exposed to daylight or specific wavelengths of light using various light sources dependent on the clinical indication. (
  • The effects of phototherapy on herpes lesions have been clinically demonstrated by either preventing the lesion formation or speeding their repair. (
  • Laser phototherapy, which is based on non-thermal photobiological processes, has been shown to modulate the body's own immune response, both locally and systemically, with a strong influence on for example cytokine production and heat-shock protein synthesis. (
  • Laser phototherapy may therefore be an important component in the overall efficacy of laser immunotherapy, and may tip the balance between the immunosuppressive and immunostimulatory forces in favor of immunostimulation. (
  • Abstract Background The purpose of this study was to analyze olfactory ensheathing cell (OEC) proliferation and growth on Biosilicate and collagen bioscaffolds, and to determine whether the application of laser phototherapy would result in increased OEC proliferation on the scaffolds. (
  • As in vitro OEC growth is a slow process, laser phototherapy could be useful to stimulate proliferation on bioscaffolds. (
  • Laser phototherapy resulted in a reduction in cell growth on the Biosilicate scaffolds and an increase in cell proliferation on collagen scaffolds. (
  • Future research combining laser phototherapy and glass-ceramic scaffolds should take into account possible interactions of the laser with matrix compounds. (
  • The research report " Phototherapy Equipment Market - Global Industry Analysis 2019 - 2025" offers precise analytical information about the Phototherapy Equipment market. (
  • Under the experimental conditions of this study we concluded that phototherapy is capable of enhancing epithelial cell growth and prolonging cell viability of HSV-1 infected cells. (
  • This Phototherapy Equipment market report bestows with the plentiful insights and business solutions that will support our clients to stay ahead of the competition. (
  • Intervention: Babies were enrolled on consecutive basis and after randomization were allocated to receive phototherapy by CFL or STL. (
  • [ 70 ] Moreover, although it did not reach statistical significance, the group that received phototherapy during transport also had an increased reduction in serum bilirubin levels from before to after transport compared to the group that did not receive phototherapy during transport. (
  • To test whether the combined use of total plasma/serum bilirubin (TSB) levels and clinical risk factors more accurately identifies infants who receive phototherapy than does the use of either method alone. (
  • Preterm Babies: Preterm infants have about a 20% increase in transepidermal water loss when they receive phototherapy despite being nursed in humidity and a double walled incubator. (
  • Albany, NY -- ( SBWIRE ) -- 09/25/2017 -- The global phototherapy equipment market was valued at US$415.0 mn in 2015 and is poised to rise to US$603.2 mn by 2024, progressing at a CAGR of 4.4% from 2016 to 2024. (
  • Geographically, North America held a dominant share of about 40.0% in the global phototherapy equipment market in 2015. (
  • With the introduction of new and innovative technologies, the global phototherapy equipment market is anticipated to tread along a healthy growth track. (
  • Besides this, the increasing stringency in regulations pertaining to their approval is rendering it difficult for new players to enter the arena, thus restricting the scope of expansion of the global phototherapy equipment market, Furthermore, rapid advancements and developments in the medical science sector have paved way for various alternative modes of treatment. (
  • Nevertheless, the increasing initiatives by key players to promote phototherapy outreach and the presence of favorable reimbursement policies in emerging countries are offering immense growth opportunities to the global phototherapy equipment market. (
  • The global phototherapy equipment market exhibits a high degree of competition. (
  • These strategies are intensifying the competition prevailing in the global phototherapy equipment market, in order to sustain which key companies are focusing on pricing strategies and product upgradation with new technologies to stay ahead," says TMR's lead analyst. (
  • The Global Phototherapy Market is expected to grow at a steady rate during the forecast period 2017-2023. (
  • GE Healthcare (UK), Koninklijke Philips N.V. (Netherlands), Natus Medical Incorporated (U.S.), Beurer GmbH (Germany), Herbert Waldmann GmbH & Co. KG (Germany), PhotoMedex, Inc (U.S.), MTTS ASIA (Vietnam), VIA Global Health (U.S.), are some of the prominent players at the forefront of competition in the Global Phototherapy Market and are profiled in MRFR Analysis. (
  • The number of key market player involved in mergers and acquisition was comparatively low, the market players which were involved in mergers and acquisition are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc. and others in the Global Phototherapy market. (
  • The Global Phototherapy Market is segmented into the various regions including Americas, Europe, Asia Pacific, and the Middle East & Africa. (
  • Future Market Insights (FMI) has composed a comprehensive report on global phototherapy lamps market for the forecast period (2017-2026). (
  • The report provides insightful forecasts related to global phototherapy lamps market's growth, and examines the market in detail, while providing important market dynamics inclusively. (
  • An abstract of global phototherapy lamps market has been delivered in this chapter. (
  • A chapter titled overview succeeds the global phototherapy lamps market's executive summary, and includes the definition of "phototherapy lamps", which follows an incisive market introduction. (
  • The overview chapter indicates clear scenario of the global phototherapy lamps market's scope. (
  • Global phototherapy lamps market is characterized regionally into Latin America, North America, Asia-Pacific excluding Japan (APEJ), Japan, Middle East & Africa (MEA), and Europe. (
  • Analysis on the global phototherapy lamps market's competition landscape has been provided in this report, along with information on active industries contributing significantly to expansion of the market. (
  • This research methodology employed relies entirely upon primary & secondary researches, to achieve necessary information on global phototherapy lamps market. (
  • Patients with eye disorders should consult an ophthalmologist before being treated with any form of phototherapy. (
  • When looking at the broad antipruritic effect of phototherapy the question arises how phototherapy is capable of reducing pruritus in such a variety of inflammatory skin and systemic diseases with obviously very different pathophysiological backgrounds? (
  • Typically, the only side effect of phototherapy is dehydration, which means that infants receiving the treatment may need intravenous fluids. (
  • The curative effect of phototherapy is explained by the fact that ultraviolet radiation stimulates metabolic processes in cells and tissues and has a local immunomodulatory effect. (
  • In January 2014, we analysed all patients recently referred for, currently receiving or recently having completed a course of phototherapy at a university teaching hospital in England (UK). (
  • Of those who completed their course of phototherapy, 80% achieved a clear/near clear or moderate response, while just two patients (8%) had minimal response and two (8%) had worsening of the disease during treatment. (
  • Conducting a course of phototherapy by CPL contributes to positive change in membrane phospholipids of these cells. (
  • The new designs available are cheaper and more advanced, which has stirred up the demand for phototherapy equipment in developing countries. (
  • The demand for phototherapy is high across the globe. (
  • We initially scheduled ten sessions of phototherapy applied to the thigh every ten days, each lasting one minute, but we observed an improvement shortly after the fourth session and sacrificed the rats to analyze their sciatic nerves. (
  • Even in the various forms of chronic prurigo ( 6 ), including the severe nodular and umbilicated ulcer types, as well as in chronic idiopathic pruritus mainly in elderly patients, phototherapy is very effective and sometimes the only treatment improving chronic pruritus ( 5 , 7 ). (
  • You will be using a portable phototherapy device known as a biliblanket. (
  • Now there are a number of portable phototherapy devices that make home therapy easy and safe. (
  • This guideline provides health care providers with information to understand the causes of neonatal jaundice, the rationale for the use of phototherapy and outlines the care of neonates receiving phototherapy in order to enhance effective phototherapy delivery and minimise complications of phototherapy. (
  • We obtained data on home and inpatient phototherapy, covariates, and cancer incidence from electronic records. (
  • 3 Many clinicians initiate phototherapy at levels lower than those recommended by the American Academy of Pediatrics. (
  • The authors of the 2004 AAP guideline offer the option of This slippery slope effect is dramatically illustrated in the beginning phototherapy 2.0 to 3.0 mg/dL below the treat- 1 2 1 report by Wickremasinghe et al in this issue of JAMA Pediatrics. (
  • One patient with dementia was deemed not safe to embark on phototherapy, and five patients were yet to start. (
  • In this small survey, the first of its kind to focus on elderly patients, phototherapy appears to be well-tolerated, safe and efficacious in the short term. (
  • Many patients find that phototherapy leaves skin looking and feeling symptom-free, without rash, redness or itchiness. (
  • It has been seen that patients who are treated with needling and phototherapy show better response in terms of repigmentation than those treated with phototherapy alone. (
  • Phototherapy using this diode laser source was effective and well tolerated in acne patients, suggesting that this phototherapy may be a new modality for the treatment of acne. (
  • This study evaluated the use of phototherapy in the healing of mixed leg ulcers in two diabetic patients (type 2) with arterial hypertension. (
  • Phototherapy accelerated wound healing of leg ulcers in diabetic patients. (
  • In this manner, we are trying to demonstrate the use of phototherapy (660/890nm LEDs) associated to topical silver sulphadiazine in the healing of leg ulcers in two diabetic patients. (
  • NB-UVB phototherapy results in satisfactory repigmentation in our vitiligo patients and should be offered as a treatment option. (
  • Phototherapy is already a standard treatment for skin allergies, so why not try it for nasal allergy symptoms? (
  • Blue fluorescent lamps with emission peak wavelength matching the absorption maximum of the plasma bilirubin-albumin complex at 460 nm have been used successfully in phototherapy, in particular the Philips F20WT12/BB special blue lamp with peak emission at 446 nm and the Philips 20WTL/52 blue lamp with peak emission at 452 nm and spectral width (width at half maximum) of 55 nm. (
  • CONCLUSIONS: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. (
  • To put this in perspective, phototherapy, along with photosensitizing chemical substances, finds application in photodynamic therapy to treat cancer. (
  • I found 983 clinical trials on phototherapy at, of which 27 are related to allergy. (
  • Prediction of postdischarge phototherapy was similar for combined clinical risk factors (earlier gestational age [GA], bruising, positive direct antiglobulin test, Asian race, exclusive breastfeeding, blood type incompatibility, jaundice extent) and age-adjusted TSB (area under the curve [AUC] = .86 vs .87), but combined screening was better (AUC = .95). (
  • Predischarge TcB/TSB (adjusted for postnatal age) combined with specific clinical factors (especially GA) best predicts subsequent phototherapy use. (
  • Phototherapy in peripheral nerve regeneration: From basic science to clinical study. (
  • Animal and clinical studies show the promoting action of phototherapy on peripheral nerve regeneration, making it possible to suggest that the time for broader clinical trials has arrived. (
  • Phototherapy, in addition, is also effective against chronic pruritus in systemic diseases such as end-stage renal disease, cholestatic liver disease (e.g., primary biliary cholangitis or cholestatic pruritus of pregnancy), hematologic diseases (e.g., polycythemia vera or Hodgkins lymphoma) and other conditions of chronic pruritus without primary or secondary skin lesions (e.g., drug induced pruritus after hydroxyethyl starch) ( 4 , 5 ). (
  • Oral phototherapy applicators are disclosed that are sized and shaped so as to fit at least partially in a user's mouth and have at least one radiation emitter coupled to an apparatus body to irradiate a portion of the oral cavity with phototherapeutic radiation, the emitter being capable of delivering. (
  • Alternatively, the apparatus body can be adapted for placement in a fixed position relative to the oral cavity during phototherapy. (
  • A UV phototherapy apparatus has a base unit containing a UVB arc lamp and an output port for delivery of UVB radiation within a predetermined range. (
  • The distance from the phototherapy apparatus to the surface of the infants was about 32 cm. (